<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01885754</url>
  </required_header>
  <id_info>
    <org_study_id>20878</org_study_id>
    <nct_id>NCT01885754</nct_id>
  </id_info>
  <brief_title>Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer</brief_title>
  <official_title>Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: With 1.6 million new cases diagnosed each year and 1.3 million deaths, lung cancer
      is the leading cancer-related death worldwide and it represents a pressing health issue.
      Patients with lung cancer are more likely to experience cachexia, a severe debilitating
      disorder causing fatigue, weight loss, muscle wasting and associated with reduced physical
      function, increased chemotherapy toxicity and reduced survival. This syndrome occurring in
      about 80% of advanced cancer patients is the direct cause of death in about 20% of cases.
      However, despite the importance of cachexia in lung cancer, its mechanisms ans its relation
      with muscle function and effort tolerance are still unknown.

      Aim: To explore muscle function, signaling pathways and its relationship to impaired
      functional capacity of patients with non-small-cell lung cancer(NSCLC); depending of whether
      they have cachexic state at diagnosis.

      Methods: This study will be conducted at the Institut universitaire de cardiologie et de
      pneumologie de Québec. 56 patients newly diagnosed of NSCLC will be recruited and separated
      whether or not they have a cachexic state. The evaluation will need two visits separated by 5
      days.

      During the evaluation the following tests will be done:

        -  Anthropometric measures

        -  Level of daily physical activity

        -  Pulmonary function test

        -  Maximal incremental cardiopulmonary exercise test on ergocycle

        -  Endurance test on ergocycle

        -  Muscle function tests

        -  Magnetic stimulation

        -  Quadriceps biopsy
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal quadriceps strength</measure>
    <time_frame>1 day (at the time of the diagnosis before any treatment)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exercise capacity</measure>
    <time_frame>1 day (at the time of the diagnosis before any treatment)</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Non-Small-cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Lung cancer patient with cachexia</arm_group_label>
    <description>Muscle lumbar area &lt; 55cm2/m2 for men and &lt; 39 cm2/m2 for women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lung cancer patients without cachexia</arm_group_label>
    <description>Muscle lumbar area over 55cm2/m2 for men and 39 cm2/m2 for women</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Quadriceps Biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with NSCLC
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women with a primary lung cancer diagnosis

        Exclusion Criteria:

          -  Already have undertaken surgery, chemotherapy or radiotherapy treatment

          -  Having an other cancer in the last five years

          -  Taking anticoagulation therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Didier Saey, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut universitaire de cardiologie et de pneumologie de Québec</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier Saey, PhD</last_name>
      <phone>418-656-8711</phone>
      <phone_ext>2614</phone_ext>
      <email>didier.saey@criucpq.ulaval.ca</email>
    </contact>
    <investigator>
      <last_name>Didier Saey, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2013</study_first_submitted>
  <study_first_submitted_qc>June 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2013</study_first_posted>
  <last_update_submitted>January 5, 2017</last_update_submitted>
  <last_update_submitted_qc>January 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</investigator_affiliation>
    <investigator_full_name>Didier Saey</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Biopsy</keyword>
  <keyword>Maximal incremental cardiopulmonary test</keyword>
  <keyword>Muscle strength test</keyword>
  <keyword>magnetic stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

